Measles Virus Infection in Pediatric Liver Transplantation Recipients

Y Liu1, L-Y Sun1, Z-J Zhu1

  • 1Liver Transplant Section, Capital Medical University Affiliated Beijing Friendship, Hospital, Beijing, China.

Transplantation Proceedings
|December 19, 2015
PubMed
Abstract

Insights

Pediatric liver transplant recipients with measles face severe risks, particularly pneumonia. Early treatment is crucial for these immunocompromised children to prevent fatal outcomes like respiratory failure.

Area of Science:

  • Pediatric Hepatology
  • Infectious Diseases
  • Transplant Immunology

Background:

  • Measles poses a significant threat to immunocompromised individuals.
  • Pediatric liver transplant recipients are a vulnerable population with altered immune status.

Purpose of the Study:

  • To analyze the clinical characteristics and outcomes of measles infection in pediatric liver transplant recipients.
  • To identify risk factors and complications associated with measles in this specific patient group.

Main Methods:

  • Retrospective data analysis of five pediatric liver transplant recipients diagnosed with measles.
  • Data collected from the Liver Transplant Section, Beijing Friendship Hospital, China, between March and April 2014.

Main Results:

  • Measles presented with severe clinical manifestations in pediatric liver transplant recipients.
  • Complications included pneumonia (3 cases) and laryngitis (1 case).
  • Two patients developed severe measles pneumonia, leading to respiratory failure and mechanical ventilation; one patient died from respiratory failure.

Conclusions:

  • Pediatric liver transplant recipients with measles are at high risk for severe pneumonia and fatal outcomes.
  • Measles pneumonitis is a frequent and often fatal complication in immunocompromised pediatric patients.
  • Prompt initiation of treatment is essential for improving outcomes.